Breakthrough Innovation: The HAART Aortic Annuloplasty Device Cleared by the FDA
Article by Adam Pick – Patient, Author & HeartValveSurgery.com Founder
“A renaissance is taking place in the world of aortic valve repair.
While patients have benefited from advances in mitral valve repair procedures (long-term durability, freedom from re-operation and normal life expectancy), reproducing those results using aortic valve repair techniques has been challenging.
Unfortunately, patients with aortic valve regurgitation – also known as aortic insufficiency – had limited treatment options, including tissue and mechanical heart valve replacement devices.
In case you missed it… The HAART Aortic Annuloplasty Device received clearance from the U.S. Food & Drug Administration (FDA). This is a very important development for patients who are searching for a potential long-term fix for their leaking aortic valves. The great news is that the early operative results using the HAART device have supported a global trend toward aortic valve repair.”
HeartValveSurgery.com is a website founded by Adam Pick, a former, double heart valve surgery patient, whose mission is to educate and empower patients, their families and friends — from diagnosis to recovery. HeartValveSurgery.com is a tremendous resource and has “helped over 10 million people better understand their valvular disorders and their treatment options.”
About BioStable Science & Engineering
BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease. The company’s HAART Aortic Repair Technologies are designed to simplify and standardize aortic valve repair, enabling surgeons to offer the recognized clinical benefits of valve repair to patients undergoing surgical correction of aortic insufficiency or aortic root aneurysm.
Please contact us for more information.